Naringenin-4'-Glucuronide as a New Drug Candidate Against the Covid-19 Omicron Variant: a Study Based on Molecular Docking, Molecular Dynamics, Mm/Pbsa and Mm/Gbsa
AuthID
P-00Y-M3V
P-00Y-M3V
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service